These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6138411)

  • 1. Pharmacokinetics of indocyanine green in rats with chronic renal failure.
    Yates MS; Emmerson J; Bowmer CJ
    J Pharm Pharmacol; 1983 Sep; 35(9):593-4. PubMed ID: 6138411
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of acute renal failure on the pharmacokinetics of indocyanine green in the rat.
    Bowmer CJ; Yates MS; Emmerson J
    Biochem Pharmacol; 1982 Aug; 31(15):2531-8. PubMed ID: 7126265
    [No Abstract]   [Full Text] [Related]  

  • 3. Delayed biliary excretion of indocyanine green in rats with glycerol-induced acute renal failure.
    Bowmer CJ; Emmerson J; Yates MS
    Biochem Pharmacol; 1983 May; 32(10):1641-2. PubMed ID: 6860349
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of acute renal failure on the clearance and biliary excretion of indocyanine green in perfused rat liver.
    Yates MS; Bowmer CJ; Emmerson J
    Biochem Pharmacol; 1984 May; 33(10):1695-6. PubMed ID: 6732839
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetics and biliary excretion of rose bengal in rats with acute and chronic renal failure.
    Silberstein DJ; Bowmer CJ; Yates MS
    J Pharm Pharmacol; 1987 May; 39(5):395-8. PubMed ID: 2886591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of the normal pattern of renal choline metabolism during uremia in rats.
    Bean GH; Knight DS; Lowenstein LM
    Nephron; 1981; 28(4):204-6. PubMed ID: 7301006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degradation and metabolism of indocyanine green: high-pressure liquid chromatographic analysis.
    Igarashi H; Kamisaka K; Maezawa H; Uesugi T
    Bull Tokyo Med Dent Univ; 1990 Dec; 37(4):59-69. PubMed ID: 2091869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of effect of cimetidine on indocyanine green extraction and clearance by the rat liver.
    Bruck R; Krepel Z; Bar-Meir S
    Isr J Med Sci; 1988 Jul; 24(7):349-50. PubMed ID: 3403233
    [No Abstract]   [Full Text] [Related]  

  • 9. Copper metabolism in uremia: effect of dialysis and zinc supplementation.
    Mahajan SK; Rye D; Sondheimer JH; McDonald FD
    Trans Am Soc Artif Intern Organs; 1985; 31():521-5. PubMed ID: 3837501
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatic clearance of indocyanine green during the course of glycerol-induced acute renal failure in the rat.
    Yates MS; Emmerson J; Bowmer CJ
    J Pharm Pharmacol; 1983 May; 35(5):335-8. PubMed ID: 6134810
    [No Abstract]   [Full Text] [Related]  

  • 11. [Catabolic speed of albumin during peritoneal dialysis in chronic and acute uremia].
    Mariani G; Bianchi R; Pilo A; Carmassi F; Paêla R; Toni MG; Bonaguidi F
    J Urol Nephrol (Paris); 1974 Sep; 80(9):808-17. PubMed ID: 4463260
    [No Abstract]   [Full Text] [Related]  

  • 12. [Evaluation of the activity of the adrenergic and serotoninergic systems in chronic renal failure in humans and in rats with experimental uremia].
    Ksiazek A
    Pol Tyg Lek; 1978 Jun; 33(26):1045-6. PubMed ID: 212718
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of prolonged uremia on insulin-like growth factor-I receptor autophosphorylation and tyrosine kinase activity in kidney and muscle.
    Tsao T; Fervenza F; Friedlaender M; Chen Y; Rabkin R
    Exp Nephrol; 2002; 10(4):285-92. PubMed ID: 12097832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Liver capacity in the biotransformation of drugs in patients with chronic circulatory failure (kinetics of antipyrine and indocyanine green)].
    Adamska-Dyniewska H
    Pol Arch Med Wewn; 1978 Oct; 60(4):313-8. PubMed ID: 714726
    [No Abstract]   [Full Text] [Related]  

  • 15. The plasma clearance of indocyanine green in rats with acute renal failure: effect of dose and route of administration.
    Yates MS; Bowmer CJ; Emmerson J
    Biochem Pharmacol; 1983 Oct; 32(20):3109-14. PubMed ID: 6639679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium and phosphorus metabolism in uremia and renal transplantation: an experimental model.
    Mitchell TS; Lee S; Gittes RF
    Invest Urol; 1974 Nov; 12(3):186-92. PubMed ID: 4613687
    [No Abstract]   [Full Text] [Related]  

  • 17. Lignocaine and indocyanine green kinetics in patients following myocardial infarction.
    Bax ND; Tucker GT; Woods HF
    Br J Clin Pharmacol; 1980 Oct; 10(4):353-61. PubMed ID: 7448106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma and brain catecholamines in experimental uremia: acute and chronic studies.
    Ali F; Tayeb O; Attallah A
    Life Sci; 1985 Nov; 37(19):1757-64. PubMed ID: 3932803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of H2-receptor antagonists on steady-state extraction of indocyanine green and lidocaine by the perfused rat liver.
    Roberts RK; Heath CA; Johnson RF; Speeg KV; Schenker S
    J Lab Clin Med; 1986 Feb; 107(2):112-7. PubMed ID: 2868064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal absorption of arachidonic acid in experimental azotemia.
    Pahl MV; Barbari A; Vaziri ND; Hollander D; Sanchez M; Oveisi F; Patel N
    Life Sci; 1990; 46(23):1649-56. PubMed ID: 2113152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.